Anjali Singh

Anjali Singh, Ph.D., currently serves as Manager of Project Management and Strategic Operations at Vertex Pharmaceuticals, a position held since December 2022. Prior to this role, Anjali held the position of Lead Scientist in Viral Vector Services at Thermo Fisher Scientific from October 2020 to November 2022 and worked as Scientist I at Izon Science from September 2019 to August 2020. Anjali's earlier experiences include a Global Scholar role at PreScouter, Inc. and a Doctoral Candidate position at Delhi University, where significant research contributions were made, including the development of a clinical protocol for gallbladder carcinoma biomarkers. Anjali's early career included a PhD clinical internship at Ranbaxy, focusing on bioequivalence studies, and a Research Assistant role at Jamia Hamdard, where research on liver-targeted nanoparticulate systems was conducted. Anjali Singh holds a PhD in Pharmaceutical Medicine from Delhi University, as well as an MPharm and BPharm from Jamia Hamdard.